Optimization of Enzyme Essays to Enhance Reliability of Activity Measurements in Leukocyte Lysates for the Diagnosis of Metachromatic Leukodystrophy and Gangliosidoses

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2020 Dec 2

PMID 33260765

Citations 8

Authors

Sebastian Strobel

Naomi Hesse

Vidiyaah Santhanakumaran

Samuel Groeschel

Gernot Bruchelt

Ingeborg Krageloh-Mann

Judith Bohringer

Affiliations

Soon will be listed here.

Abstract

(1) Lysosomal storage diseases are rare inherited disorders with no standardized or commercially available tests for biochemical diagnosis. We present factors influencing the quality of enzyme assays for metachromatic leukodystrophy (MLD) and gangliosidoses (GM1; GM2 variants B and 0) and validate the reliability and stability of testing in a retrospective analysis of 725 samples. (2) Patient leukocytes were isolated from ethylene-diamine-tetra-acetic acid (EDTA) blood and separated for subpopulation experiments using density gradient centrifugation or magnetic cell separation. Enzyme activities in whole leukocyte lysate and leukocyte subpopulations were determined. (3) The enzyme activities in leukocyte subpopulations differed significantly. Compared to lymphocytes, the respective enzyme activities were 2.31-4.57-fold higher in monocytes and 1.64-2.81-fold higher in granulocytes. During sample preparation, a considerable amount of the lysosomal enzymes was released from granulocytes. Nevertheless, with the sample preparation method used here, total leukocyte count proved to be more accurate than total protein amount as a reference unit for enzyme activities. Subsequent analysis of 725 individuals showed clear discrimination of enzyme activities in patient samples (48 MLD; 21 gangliosidoses), with a sensitivity of 100% and specificity of 98-99%.

Citing Articles

Analysis of the measurements used as potency tests for the 31 US FDA-approved cell therapy products.

Simon Jr C, Bozenhardt E, Celluzzi C, Dobnik D, Grant M, Lakshmipathy U J Transl Med. 2025; 23(1):259.

PMID: 40038737 PMC: 11877884. DOI: 10.1186/s12967-025-06253-4.

Validation of high-sensitivity assays to quantitate cerebrospinal fluid and serum β-galactosidase activity in patients with GM1-gangliosidosis.

Quadrini K, Vrentas C, Duke C, Wilson C, Hinderer C, Weinstein D Mol Ther Methods Clin Dev. 2024; 32(3):101318.

PMID: 39282076 PMC: 11401230. DOI: 10.1016/j.omtm.2024.101318.

A multiplexed targeted method for profiling of serum gangliosides and glycosphingolipids: application to GM2-gangliosidosis.

Kim J, Byeon S, Oglesbee D, Schultz M, Matern D, Pandey A Anal Bioanal Chem. 2024; 416(26):5689-5699.

PMID: 39190143 PMC: 11493836. DOI: 10.1007/s00216-024-05487-3.

Best Practices for Development and Validation of Enzymatic Activity Assays to Support Drug Development for Inborn Errors of Metabolism and Biomarker Assessment.

Azadeh M, Good J, Gunsior M, Kulagina N, Lu Y, McNally J AAPS J. 2024; 26(5):97.

PMID: 39179710 DOI: 10.1208/s12248-024-00966-y.

Biochemical and molecular analysis of pediatric patients with metachromatic leukodystrophy in South China: functional characterization of five novel ARSA variants.

Li T, Huang Y, Tao C, Yin X, Su X, Shao Y Metab Brain Dis. 2024; 39(5):753-762.

PMID: 38775997 DOI: 10.1007/s11011-024-01348-1.

References

Groeschel S, Kuhl J, Bley A, Kehrer C, Weschke B, Doring M . Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients. JAMA Neurol. 2016; 73(9):1133-40. DOI: 10.1001/jamaneurol.2016.2067. View

Bohringer J, Santer R, Schumacher N, Gieseke F, Cornils K, Pechan M . Enzymatic characterization of novel arylsulfatase A variants using human arylsulfatase A-deficient immortalized mesenchymal stromal cells. Hum Mutat. 2017; 38(11):1511-1520. DOI: 10.1002/humu.23306. View

Ruijter G, Boer M, Weykamp C, de Vries R, van den Berg I, Janssens-Puister J . External quality assurance programme for enzymatic analysis of lysosomal storage diseases: a pilot study. J Inherit Metab Dis. 2006; 28(6):979-90. DOI: 10.1007/s10545-005-0201-z. View

Chang P, Wu T, Hung C, Tsao K, Sun C, Wu L . Development of an ELISA for myeloperoxidase on microplate: normal reference values and effect of temperature on specimen preparation. Clin Chim Acta. 2006; 373(1-2):158-63. DOI: 10.1016/j.cca.2006.05.030. View

Leinekugel P, Michel S, Conzelmann E, Sandhoff K . Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet. 1992; 88(5):513-23. DOI: 10.1007/BF00219337. View

Dali C, Sevin C, Krageloh-Mann I, Giugliani R, Sakai N, Wu J . Safety of intrathecal delivery of recombinant human arylsulfatase A in children with metachromatic leukodystrophy: Results from a phase 1/2 clinical trial. Mol Genet Metab. 2020; 131(1-2):235-244. DOI: 10.1016/j.ymgme.2020.07.002. View

Conzelmann E . A simple chromogenic assay for arylsulfatase A. Clin Chim Acta. 1987; 164(2):171-80. DOI: 10.1016/0009-8981(87)90068-4. View

Nakagawa S, KUMIN S, Fox D, NITOWSKY H . Human hexosaminidase isozymes. III. Distribution and activity of isozymes in peripheral blood leukocytes and platelets. J Lab Clin Med. 1978; 91(6):922-8. View

Leckie M, Gomma A, Purcell I, Nyawo B, Dewar A, Okrongly D . Automated quantitation of peripheral blood neutrophil activation in patients with myocardial ischaemia. Int J Cardiol. 2004; 95(2-3):307-13. DOI: 10.1016/j.ijcard.2003.04.063. View

10.

Burin M, Brum J, Mauricio T, Amorim M, Giugliani R . Effect of collection, transport, processing and storage of blood specimens on the activity of lysosomal enzymes in plasma and leukocytes. Braz J Med Biol Res. 2000; 33(9):1003-13. DOI: 10.1590/s0100-879x2000000900003. View

11.

Bouwman M, Teunissen Q, Wijburg F, Linthorst G . 'Doctor Google' ending the diagnostic odyssey in lysosomal storage disorders: parents using internet search engines as an efficient diagnostic strategy in rare diseases. Arch Dis Child. 2010; 95(8):642-4. DOI: 10.1136/adc.2009.171827. View

12.

Simon M, Roi L, Desai S, Salberg D, Rose N . Comparison of cultures of human lymphocytes obtained following NH4Cl induced red blood cell lysis and Ficoll-Hypaque density gradient centrifugation. Immunol Commun. 1983; 12(3):301-14. DOI: 10.3109/08820138309050752. View

13.

Sessa M, Lorioli L, Fumagalli F, Acquati S, Redaelli D, Baldoli C . Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial. Lancet. 2016; 388(10043):476-87. DOI: 10.1016/S0140-6736(16)30374-9. View

14.

Sandhoff K, Harzer K . Gangliosides and gangliosidoses: principles of molecular and metabolic pathogenesis. J Neurosci. 2013; 33(25):10195-208. PMC: 6618597. DOI: 10.1523/JNEUROSCI.0822-13.2013. View

15.

Suzuki K . Enzymic diagnosis of sphingolipidoses. Methods Enzymol. 1978; 50:456-88. DOI: 10.1016/0076-6879(78)50049-9. View

16.

Schmidt R, von Figura K, Paschke E, Kresse H . Sanfilippo's disease type A: sulfamidase activity in peripheral leukocytes of normal, heterozygous and homozygous individuals. Clin Chim Acta. 1977; 80(1):7-15. DOI: 10.1016/0009-8981(77)90258-3. View

17.

Elbin C, Olivova P, Marashio C, Cooper S, Cullen E, Keutzer J . The effect of preparation, storage and shipping of dried blood spots on the activity of five lysosomal enzymes. Clin Chim Acta. 2011; 412(13-14):1207-12. DOI: 10.1016/j.cca.2011.03.012. View

18.

Kehrer C, Elgun S, Raabe C, Bohringer J, Beck-Wodl S, Bevot A . Association of Age at Onset and First Symptoms With Disease Progression in Patients With Metachromatic Leukodystrophy. Neurology. 2020; 96(2):e255-e266. DOI: 10.1212/WNL.0000000000011047. View

19.

Beutler E, KUHL W, Matsumoto F, Pangalis G . Acid hydrolases in leukocytes and platelets of normal subjects and in patients with Gaucher's and Fabry's disease. J Exp Med. 1976; 143(4):975-80. PMC: 2190173. DOI: 10.1084/jem.143.4.975. View

20.

van Rappard D, Boelens J, Wolf N . Metachromatic leukodystrophy: Disease spectrum and approaches for treatment. Best Pract Res Clin Endocrinol Metab. 2015; 29(2):261-73. DOI: 10.1016/j.beem.2014.10.001. View